Human Papillomavirus (HPV) Vaccines

Human Papillomavirus (HPV) Vaccines Submit Abstract Register Now

Genital human papillomavirus (HPV) is the most common sexually transmitted virus in the U.S. Vaccine Can is given starting at 9 years of age. HPV is also associated with several less common types of cancer in both men and women. It can also cause genital warts and warts in the upper respiratory tract. More than 50% of sexually active men and women are infected with HPV at some time in their lives.

  • Adverse Reactions and Drug Interactions
  • Contraindications and precautions
  • Dosage Forms, Strengths and Contraindications
  • HPV Vaccination
  • Indication and Usage – Dosage and Administration

Related Conference of Human Papillomavirus (HPV) Vaccines

September 21-22, 2026

44th Euro Global Summit and Expo on Vaccines & Vaccination

Barcelona, Spain
September 28-29, 2026

8th World Congress on Vaccine and Immunology

Toronto, Canada
November 16-17, 2026

7th International Conference on Vaccine Research

Tokyo, Japan

WORLD VACCINES 2027

March 24-25, 2027

10th International Conference on Vaccines, Immunology and Clinical Trials

Paris, France
July 27-28, 2027

8th International conference on Vaccines, Vaccination and Immunization

Paris, France

Human Papillomavirus (HPV) Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in